🔗 Share this article

An underground market for unapproved weight-loss drugs is propelled by social media fitness personalities and sellers on messaging platforms, according to recent findings.

Experimental Treatment Gaining Traction Via Social Media

The experimental drug, which is still in research studies, is being advertised by online personalities for its supposed fat-burning properties. Followers are urged to message these accounts privately for source information, while also obtaining discount codes.

Thriving Trade on Messaging Platforms

Additionally, a flourishing trade exists on Telegram, where groups with thousands of members share comparison images, injection guides and claims of next-day UK delivery. Sellers promote the drug there before directing customers to other platforms for transactions.

Learning About The Experimental Drug

Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Professionals Voice Concerns

However, physicians and pharmacists have warned that the distribution of what is still an unapproved drug in the United Kingdom is worrisome and could result in individuals injecting substances of unknown origin.

Several experts stated the popularity for retatrutide could be connected to the increasing cost of licensed weight loss treatments such as Mounjaro.

Legal Status and Enforcement

Marketing the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that cannot be marketed or distributed for human use under the British medical regulations.

Several influencers try to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still violate medicines, advertising, and customer laws, potentially leading to penalties, legal action or prison.

Service Response and Material Removal

Based on TikTok, the service has taken down problematic material and banned associated keywords and query recommendations. The company said it was committed to maintaining the platform secure and investing in enhancing compliance measures.

Digital Marketplace Operations

Investigations also discovered groups with up to nine thousand participants selling the experimental drug using the platform's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” instantly displays groups with thousands of users, populated with photos of weight loss, positive reviews and step-by-step instructions for preparing or injecting at residence.

After moments of joining one community, a vendor shared contact information, where most purchases occur. The vendor provided an guidebook and promised delivery within 48 hours. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a image of a supposed testing documentation. None asked about body mass, health issues or past usage.

Item Details and Costs

Inside these communities, posts show black plastic parcels with postal service stickers, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at residence with purified liquid, or pre-filled injectors usually priced at £160 for 20 milligrams. When asked how long a pen should be used, vendors give contradictory responses varying between a few weeks to “depends on your body”.

Service Moderation and Safety Measures

A spokesperson for the messaging service said it regularly moderated dangerous content on its service including content that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting substances they cannot confirm. Even if the science behind this drug is sound, these digital products may not include what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor linked the increase in demand to current price rises for approved weight-loss drugs such as Mounjaro. “With costs rising, patients are turning to online platforms. But fake injections are highly dangerous. You cannot know what’s inside or whether the environment they were made in was sterile,” she said.

Her team has already encountered individuals injured by personal administration from unverified sources. “We recognize the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” stated the doctor. “These materials could be impure or improperly measured.”

Manufacturer Statement

A spokesperson from the pharmaceutical company stated the substance was in phase 3 research studies and had not been reviewed or approved by any government authority globally. “Consequently at this time no one can market [it] for personal consumption,” they explained, noting that any product “misleadingly claiming itself as a Lilly experimental product not yet approved … may expose patients to potentially serious health risks”.